{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:54Z","timestamp":1786969674723,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"Abstract<\/jats:title>\n \n Background:<\/jats:title>\n The pooled cohort equation (PCE) for predicting the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) has been utilised in Black populations to predict cardiovascular events.<\/jats:p>\n <\/jats:sec>\n \n Objective:<\/jats:title>\n We explored the relationship between PCE ASCVD risk and left ventricular hypertrophy (LVH).<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n A total of 934 hypertensives from the Federal Medical Centre Abuja Hypertension Registry were analysed for this study. The participants were divided into two groups: those with low ASCVD risk (<7.5%) and those with elevated ASCVD risk (\u22657.5%). Electrocardiographic (ECG) LVH was defined by the presence of any of Sokolow-Lyon, Cornell voltage or Gubner-Ungerleider criteria. Echocardiographic LVH was defined as an elevated LV mass index using the linear cube formula of the American College of Cardiology.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Participants with elevated ASCVD risk were older (59.2 \u00b1 9.0 years) than those with low ASCVD risk (\n P<\/jats:italic>\n < 0.001). Among participants with elevated ASCVD risk, 299 (42.1%) and 181 (26.3%) had echocardiographic and ECG LVH compared with 75 (32.3%) and 44 (19.6%) in those with low ASCVD risk, respectively (\n P<\/jats:italic>\n < 0.05). Those with elevated ASCVD risk had higher odds of having echocardiographic (odds ratio [OR]: 2.02, 95% confidence interval CI 1.39\u20132.93) and ECG LVH (OR: 2.00, 95% CI 1.29\u20133.08) compared to those in the low-risk group (\n P<\/jats:italic>\n < 0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n In this study, an elevated 10-year ASCVD risk was associated with a two-fold increase in the risk of echocardiographic and ECG LVH in a population of Nigerian hypertensives. In resource-limited settings, the use of the ASCVD risk score may facilitate timely referrals for the diagnosis and management of LVH.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/npmj.npmj_580_25","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:00:21Z","timestamp":1786939221000},"page":"637-642","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of 10-year Cardiovascular Risk with Left Ventricular Hypertrophy in a Population of Nigerian Hypertensives"],"prefix":"10.4103","volume":"33","author":[{"given":"Olugbenga Olusola","family":"Abiodun","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Federal Medical Centre, Abuja, Nigeria"},{"name":"Department of Medicine, Baze University, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Anya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, NNPC MultiSpecialist Hospital, Utako, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global burden of cardiovascular diseases and risks collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjhyper.2006.10.013","article-title":"Risk-factor clustering and cardiovascular disease risk in hypertensive patients","volume":"20","author":"Weycker","year":"2007","journal-title":"Am J Hypertens"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: An open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacl.2017.09.004","article-title":"Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease","volume":"11","author":"Ofori","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R7-20260817","first-page":"100521","article-title":"Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya","volume":"28","author":"Wekesah","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10903-017-0644-y","article-title":"The association between acculturation and cardiovascular disease risk in Ghanaian and Nigerian-born African immigrants in the United States: The Afro-cardiac study","volume":"20","author":"Commodore-Mensah","year":"2018","journal-title":"J Immigr Minor Health"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12916-019-1340-7","article-title":"Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: A systematic review and meta-analysis","volume":"17","author":"Damen","year":"2019","journal-title":"BMC Med"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1573403X10666140514103220","article-title":"The role of ECG in the diagnosis of left ventricular hypertrophy","volume":"10","author":"Bacharova","year":"2014","journal-title":"Curr Cardiol Rev"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5334\/gh.1296","article-title":"Prevalence, risk factors and cardiovascular comorbidities of resistant hypertension among treated hypertensives in a Nigerian population","volume":"19","author":"Abiodun","year":"2024","journal-title":"Glob Heart"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jacc.2007.01.024","article-title":"Recommendations for the standardization and interpretation of the electrocardiogram: Part I: The electrocardiogram and its technology a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society endorsed by the International Society for Computerized Electrocardiology","volume":"49","author":"Kligfield","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R15-20260817","first-page":"e60170","article-title":"Electrocardiographic abnormalities in nigerian hypertensives with echocardiographic left ventricular hypertrophy","volume":"16","author":"Abiodun","year":"2024","journal-title":"Cureus"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: A report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejhf.3024","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"26","author":"McDonagh","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.phrs.2018.06.026","article-title":"Changes in left ventricular geometry during antihypertensive treatment","volume":"134","author":"Salvetti","year":"2018","journal-title":"Pharmacol Res"},{"key":"R28-20260817","first-page":"685","article-title":"Patterns of statin use in a real-world population of patients at high cardiovascular risk","volume":"22","author":"Lin","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"R29-20260817","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jelectrocard.2023.08.005","article-title":"ISE\/ISHNE expert consensus statement on ECG diagnosis of left ventricular hypertrophy: The change of the paradigm. The joint paper of the International Society of Electrocardiology and the International Society for Holter Monitoring and Noninvasive Electrocardiology","volume":"81","author":"Bacharova","year":"2023","journal-title":"J Electrocardiol"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_580_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:02:09Z","timestamp":1786968129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_580_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_580_25","relation":{},"ISSN":["1117-1936","2468-6875"],"issn-type":[{"value":"1117-1936","type":"print"},{"value":"2468-6875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"2025-10-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}